- call +1-201-465-4211
- email sales@mrinsights.biz
A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.
Scope of the Report:
The global Protein Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Protein Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Protein Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Protein Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson＆Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Market Segment by Applications, can be divided into
Hospitals
Clinics
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Protein Drugs Market Overview
1.1 Product Overview and Scope of Protein Drugs
1.2 Classification of Protein Drugs by Types
1.2.1 Global Protein Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Protein Drugs Revenue Market Share by Types in 2017
1.2.3 Antibody Drugs
1.2.4 Peptide Hormones
1.2.5 Blood Products
1.2.6 Enzymes
1.3 Global Protein Drugs Market by Application
1.3.1 Global Protein Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Protein Drugs Market by Regions
1.4.1 Global Protein Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Protein Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Protein Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Protein Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Protein Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Protein Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Protein Drugs (2013-2023)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Protein Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories
2.2.1 Business Overview
2.2.2 Protein Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 UCB Group
2.3.1 Business Overview
2.3.2 Protein Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 UCB Group Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Schering-Plough Corporation
2.4.1 Business Overview
2.4.2 Protein Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Schering-Plough Corporation Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genentech
2.5.1 Business Overview
2.5.2 Protein Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genentech Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson＆Johnson
2.6.1 Business Overview
2.6.2 Protein Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson＆Johnson Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Protein Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novo Nordisk
2.8.1 Business Overview
2.8.2 Protein Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novo Nordisk Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biogen Idec
2.9.1 Business Overview
2.9.2 Protein Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biogen Idec Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Dendreon Corporation
2.10.1 Business Overview
2.10.2 Protein Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Dendreon Corporation Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Amgen Inc.
2.11.1 Business Overview
2.11.2 Protein Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Amgen Inc. Protein Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Protein Drugs Market Competition, by Players
3.1 Global Protein Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Protein Drugs Players Market Share
3.2.2 Top 10 Protein Drugs Players Market Share
3.3 Market Competition Trend
4 Global Protein Drugs Market Size by Regions
4.1 Global Protein Drugs Revenue and Market Share by Regions
4.2 North America Protein Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Protein Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Protein Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Protein Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Protein Drugs Revenue and Growth Rate (2013-2018)
5 North America Protein Drugs Revenue by Countries
5.1 North America Protein Drugs Revenue by Countries (2013-2018)
5.2 USA Protein Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Protein Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Protein Drugs Revenue and Growth Rate (2013-2018)
6 Europe Protein Drugs Revenue by Countries
6.1 Europe Protein Drugs Revenue by Countries (2013-2018)
6.2 Germany Protein Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Protein Drugs Revenue and Growth Rate (2013-2018)
6.4 France Protein Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Protein Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Protein Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Protein Drugs Revenue by Countries
7.1 Asia-Pacific Protein Drugs Revenue by Countries (2013-2018)
7.2 China Protein Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Protein Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Protein Drugs Revenue and Growth Rate (2013-2018)
7.5 India Protein Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Protein Drugs Revenue and Growth Rate (2013-2018)
8 South America Protein Drugs Revenue by Countries
8.1 South America Protein Drugs Revenue by Countries (2013-2018)
8.2 Brazil Protein Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Protein Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Protein Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Protein Drugs by Countries
9.1 Middle East and Africa Protein Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Protein Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Protein Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Protein Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Protein Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Protein Drugs Revenue and Growth Rate (2013-2018)
10 Global Protein Drugs Market Segment by Type
10.1 Global Protein Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Protein Drugs Market Forecast by Type (2018-2023)
10.3 Antibody Drugs Revenue Growth Rate (2013-2023)
10.4 Peptide Hormones Revenue Growth Rate (2013-2023)
10.5 Blood Products Revenue Growth Rate (2013-2023)
10.6 Enzymes Revenue Growth Rate (2013-2023)
11 Global Protein Drugs Market Segment by Application
11.1 Global Protein Drugs Revenue Market Share by Application (2013-2018)
11.2 Protein Drugs Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 Global Protein Drugs Market Size Forecast (2018-2023)
12.1 Global Protein Drugs Market Size Forecast (2018-2023)
12.2 Global Protein Drugs Market Forecast by Regions (2018-2023)
12.3 North America Protein Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Protein Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Protein Drugs Revenue Market Forecast (2018-2023)
12.6 South America Protein Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Protein Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Protein Drugs Picture
Table Product Specifications of Protein Drugs
Table Global Protein Drugs and Revenue (Million USD) Market Split by Product Type
Fi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
